Skip to main navigation Skip to search Skip to main content

Typhoid fever

  • James E. Meiring
  • , Farhana Khanam
  • , Buddha Basnyat
  • , Richelle C. Charles
  • , John A. Crump
  • , Frederic Debellut
  • , Kathryn E. Holt
  • , Samuel Kariuki
  • , Emmanuel Mugisha
  • , Kathleen M. Neuzil
  • , Christopher Parry
  • , Virginia E. Pitzer
  • , Andrew J. Pollard
  • , Firdausi Qadri
  • , Melita A. Gordon
  • University of Sheffield
  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme
  • International Centre for Diarrhoeal Disease Research Bangladesh
  • University of Oxford
  • Harvard University
  • University of Otago
  • PATH
  • London School of Hygiene and Tropical Medicine
  • Monash University
  • Kenya Medical Research Institute
  • PATH
  • University of Maryland, Baltimore
  • Yale University
  • NIHR Oxford Biomedical Research Centre
  • University of Liverpool

Research output: Contribution to journalArticlepeer-review

64 Citations (Scopus)

Abstract

Typhoid fever is an invasive bacterial disease associated with bloodstream infection that causes a high burden of disease in Africa and Asia. Typhoid primarily affects individuals ranging from infants through to young adults. The causative organism, Salmonella enterica subsp. enterica serovar Typhi is transmitted via the faecal-oral route, crossing the intestinal epithelium and disseminating to systemic and intracellular sites, causing an undifferentiated febrile illness. Blood culture remains the practical reference standard for diagnosis of typhoid fever, where culture testing is available, but novel diagnostic modalities are an important priority under investigation. Since 2017, remarkable progress has been made in defining the global burden of both typhoid fever and antimicrobial resistance; in understanding disease pathogenesis and immunological protection through the use of controlled human infection; and in advancing effective vaccination programmes through strategic multipartner collaboration and targeted clinical trials in multiple high-incidence priority settings. This Primer thus offers a timely update of progress and perspective on future priorities for the global scientific community.

Original languageEnglish
Article number71
Pages (from-to)e71
JournalNature Reviews Disease Primers
Volume9
Issue number1
DOIs
Publication statusPublished - 14 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Themes

  • Tuberculosis and Antimicrobial Resistance

Fingerprint

Dive into the research topics of 'Typhoid fever'. Together they form a unique fingerprint.

Cite this